Cargando…

What do we know about the sleep effects of caffeine used to treat apnoea of prematurity? A systematic review of the literature

OBJECTIVE: Scientific scrutiny has proved the safety and benefits of caffeine to treat apnoea of prematurity (AOP). However, there is no consensus on the effects of this treatment on sleep, especially considering the key role of adenosine and early brain development for sleep maturation. We systemat...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Toledo, Ana Renata Pinto, Caetano, Higor Arruda, Skupien, Jovito Adiel, Boeck, Carina Rodrigues, Fiori, Humberto, da Silva, Rosane Souza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10505599/ https://www.ncbi.nlm.nih.gov/pubmed/37718322 http://dx.doi.org/10.1186/s40348-023-00166-2

Ejemplares similares

A Randomized Controlled Trial Comparing Two Doses of Caffeine for Apnoea in Prematurity
por: Mohd Kori, Anis Munirah, et al.
Publicado: (2021)

Therapies for bruxism: a systematic review and network meta-analysis (protocol)
por: Mesko, Mauro Elias, et al.
Publicado: (2017)

Risk and protective factors of Leishmaniasis in the rural area of the western border region of Rio Grande do Sul, Brazil
por: Pradella, Gabriela Döwich, et al.
Publicado: (2021)

Effectiveness and safety of early versus late caffeine therapy in managing apnoea of prematurity among preterm infants: a retrospective cohort study
por: Yun, Won Zi, et al.
Publicado: (2022)

Contributions of Zebrafish Studies to the Behavioural Consequences of Early Alcohol Exposure: A Systematic Review
por: Schaidhauer, Flavia Gheller, et al.
Publicado: (2022)

Alternative algorithms and devices in sleep apnoea diagnosis: what we know and what we expect
por: Penzel, Thomas, et al.
Publicado: (2020)

Doxapram Use for Apnoea of Prematurity in Neonatal Intensive Care
por: Prins, S. A., et al.
Publicado: (2013)

Caffeine and Clinical Outcomes in Premature Neonates
por: Kumar, Vasantha H.S., et al.
Publicado: (2019)

Premature Death in Bodybuilders: What Do We Know?
por: Smoliga, James M., et al.
Publicado: (2023)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

Comparison of Caffeine versus Theophylline for apnea of prematurity
por: Zulqarnain, Arif, et al.
Publicado: (2019)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Apnoea of Prematurity and Neurodevelopmental Outcomes: Current Understanding and Future Prospects for Research
por: Williamson, Max, et al.
Publicado: (2021)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

The Role of the Microbiome in Autism: All That We Know about All That We Don’t Know
por: David, Maude M.
Publicado: (2021)

Developing and testing a clinical care bundle incorporating caffeine citrate to manage apnoea of prematurity in a resource-constrained setting: a mixed methods clinical feasibility study protocol
por: Irimu, Grace, et al.
Publicado: (2023)

Wide variation in caffeine discontinuation timing in premature infants
por: Ji, Dabin, et al.
Publicado: (2019)

Incontinentia pigmenti: What we know and can we manage it as retinopathy of prematurity?
por: Al-Farsi, Nouf, et al.
Publicado: (2022)

What do we know about neutrinos?
por: Vannucci, François
Publicado: (1994)

Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

Influence of the root canal filling technique on the success rate of primary endodontic treatments: a systematic review
por: Marconi, Daniel Feijolo, et al.
Publicado: (2022)

Transcranial Electrical Stimulation: What We Know and Do Not Know About Mechanisms
por: Fertonani, Anna, et al.
Publicado: (2016)

What Should We Do About Habitual Caffeine Use in Athletes?
por: Pickering, Craig, et al.
Publicado: (2018)

What we know about management and organisation of primary dental care in Brazil
por: Santos, Tatiana Pereira, et al.
Publicado: (2019)

Effect of Genetic Information and Information About Caffeine Content on Caffeine Withdrawal Symptoms
por: Mills, Llewellyn, et al.
Publicado: (2017)

What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Caffeine for apnea of prematurity and brain development at 11 years of age
por: Kelly, Claire E., et al.
Publicado: (2018)

Molecular Mechanism of Caffeine in Preventing Bronchopulmonary Dysplasia in Premature Infants
por: Tian, Congliang, et al.
Publicado: (2022)

Late effects of caffeine use on sleep of infants born prematurely
por: de Oliveira, Ana Carolina Nunes, et al.
Publicado: (2023)

What we know about mathematics teaching and learning
por: McREL
Publicado: (2010)

RESCO? Now we know what is it all about!
Publicado: (1980)

What do we know about the Higgs boson ?
por: Gambino, Paulo
Publicado: (2002)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

The disordered mind: what we know about schizophrenia
por: O'Brien, P T
Publicado: (1978)

What do We Know about Neonatal Cognition?
por: Streri, Arlette, et al.
Publicado: (2013)

What We Know Currently about Mirror Neurons
por: Kilner, J.M., et al.
Publicado: (2013)

What we know about ocular manifestations of Ebola
por: Moshirfar, Majid, et al.
Publicado: (2014)

What Do We Know about Opioids and the Kidney?
por: Mallappallil, Mary, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ndffall2gfc5lcrtmmprhmdme6